Rush Launches Blood Test to Detect Over 50 Cancers Amid Industry Hesitation
Rush University is now offering the Galleri blood test, which can detect over 50 types of cancer early by identifying cancer DNA in the bloodstream, despite it not yet being FDA-approved. The test has shown promise in clinical trials and could significantly improve early cancer detection, but some health systems remain cautious due to concerns about accuracy, cost, and regulatory approval.